Skip to main content
OpenTrials

Clinical trial condition

Lennox Gastaut Syndrome

Explore clinical trials studying Lennox Gastaut Syndrome. Study availability and eligibility vary by location and protocol.

47 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Lennox Gastaut Syndrome trial results

Completed

Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome

NCT03731715

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +5 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Duke Health Durham, North Carolina, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

NCT02224560

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +5 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Los Angeles, California, United States
  • Hartford, Connecticut, United States
View all 29 locations
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

NCT02224690

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +6 more
Locations
  • Tampa, Florida, United States
  • Atlanta, Georgia, United States
  • Chicago, Illinois, United States
  • Ames, Iowa, United States
View all 24 locations
View Trial Details
Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

Conditions
Brain Diseases, Brain Ischemia, CDKL5 deficiency disorder, +35 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 44 locations
View Trial Details
Completed

Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs

NCT01405053

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +6 more
Locations
  • San Diego, California, United States
  • Aurora, Colorado, United States
  • Washington D.C., District of Columbia, United States
  • Gulf Breeze, Florida, United States
View all 47 locations
View Trial Details

Related conditions